Our Promise to Patients: You Come First
Our activities are based on our promise to save lives and to improve the lives of our patients and their families, as living with a rare disease impacts more than just one person. We offer self-help programmes and activities, and work with patient organisations to improve educational activities and raise public awareness. In addition, we work hand in hand with healthcare authorities to ensure that patients have access to the medicines they need to help them lead a full life.
How can we help you?
Immunodefiency & Autoimmune Diseases
We offer one of the most comprehensive portfolios of high-quality, technically advanced immunoglobulin (Ig) therapies and we are the leading Ig manufacturer in the world. Treatments are available for the following conditions:
Hereditary Bleeding Disorders
We are a world leader in innovative medicines for the treatment of bleeding disorders. We offer the largest portfolio for the treatment of hereditary bleeding disorders with more than a dozen plasma-derived and recombinant coagulation factor concentrates. Treatments are available for the following conditions:
Hereditary Angioedema (HAE)
We recently introduced the world's first subcutaneous preventative treatment for attacks of Hereditary Angioedema (HAE), while still offering our intravenous C1-esterase inhibitor therapy for on-demand treatment.
Alpha-1 Antitrypsin Deficiency
Our alpha-1 proteinase inhibitor treats Alpha-1 Antitrypsin Deficiency (AATD) in patients with alpha-1-related emphysema.
CSL Behring Worldwide